Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell

Patent metadata

Field	Value
Publication number	US-10822601-B2
Application number	US-201916394951-A
Country	US
Kind code	B2
Filing date	Apr 25, 2019
Priority date	Aug 24, 2011
Publication date	Nov 3, 2020
Grant date	Nov 3, 2020

Abstract

The present invention relates to methods for constructing a filamentous fungal strain for production of multiple recombinant polypeptides having biological activity. The present invention also relates to methods for producing multiple recombinant polypeptides having biological activity in a filamentous fungal strain. The present invention also relates to filamentous fungal strains expressing multiple recombinant polypeptides having biological activity.

First claim

What is claimed is:

1. A method for constructing a filamentous fungal strain for production of multiple recombinant polypeptides having biological activity, comprising:
(a) inserting into an endogenous first locus by targeted integration by homologous recombination a first tandem construct comprising (i) a homologous 5′ region of the first locus, a homologous flanking region thereof, or a combination thereof, (ii) one or more first selectable markers, (iii) a first polynucleotide encoding a first polypeptide having biological activity operably linked to a first promoter and a first terminator, (iv) a second polynucleotide encoding a second polypeptide having biological activity operably linked to a second promoter and a second terminator, and (v) a homologous 3′ region of the first locus, a homologous flanking region thereof, or a combination thereof; and
(b) inserting into an endogenous second locus by targeted integration by homologous recombination a second tandem construct comprising (i) a homologous 5′ region of the second locus, a homologous flanking region thereof, or a combination thereof, (ii) one or more second selectable markers, (iii) a third polynucleotide encoding a third polypeptide having biological activity operably linked to a third promoter and a third terminator, (iv) a fourth polynucleotide encoding a fourth polypeptide having biological activity operably linked to a fourth promoter and a fourth terminator, and (v) a homologous 3′ region of the second locus, a homologous flanking region thereof, or a combination thereof.

2. The method of claim 1 , wherein one or more of the tandem constructs further comprise a first homologous repeat flanking 5′ of the one or more selectable markers and a second homologous repeat flanking 3′ of the one or more selectable markers, wherein the first homologous repeat and the second homologous repeat undergo homologous recombination to excise the one or more selectable markers, and wherein upon the excision of the one or more selectable markers, the one or more selectable markers can be reused for modifying by insertion one or more additional endogenous loci each by targeted integration with a corresponding tandem construct for each locus.

3. The method of claim 2 , wherein the first and second homologous repeats are identical or have a sequence identity of at least 70% to each other.

4. The method of claim 2 , wherein the first and second homologous repeats are each at least 50 bp.

5. The method of claim 1 , wherein the first locus is a cellobiohydrolase I gene.

6. The method of claim 5 , wherein the cellobiohydrolase I gene encodes a cellobiohydrolase I selected from the group consisting of: (i) a cellobiohydrolase I comprising the mature polypeptide of SEQ ID NO: 2; (ii) a cellobiohydrolase I comprising an amino acid sequence having at least 70% sequence identity to the mature polypeptide of SEQ ID NO: 2; (iii) a cellobiohydrolase I encoded by a polynucleotide comprising a nucleotide sequence having at least 70% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1; and (iv) a cellobiohydrolase I encoded by a polynucleotide that hybridizes under high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 1 or the full-length complement thereof, wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide for 12 to 24 hours and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.

7. The method of claim 1 , wherein the second locus is a cellobiohydrolase II gene.

8. The method of claim 7 , wherein the cellobiohydrolase II gene encodes a cellobiohydrolase II selected from the group consisting of: (i) a cellobiohydrolase II comprising the mature polypeptide of SEQ ID NO: 4; (ii) a cellobiohydrolase II comprising an amino acid sequence having at least 70% sequence identity to the mature polypeptide of SEQ ID NO: 4; (iii) a cellobiohydrolase II encoded by a polynucleotide comprising a nucleotide sequence having at least 70% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3; and (iv) a cellobiohydrolase II encoded by a polynucleotide that hybridizes under high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 3 or the full-length complement thereof, wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide for 12 to 24 hours and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.

9. The method of claim 1 , wherein the homologous 5′ region of the first locus, the homologous flanking region thereof, or a combination thereof is at least 50 bp.

10. The method of claim 1 , wherein the homologous 3′ region of the first locus, the homologous flanking region thereof, or a combination thereof is at least 50 bp.

11. The method of claim 1 , wherein the homologous 5′ region of the second locus, the homologous flanking region thereof, or a combination thereof is at least 50 bp.

12. The method of claim 1 , wherein the homologous 3′ region of the second locus, the homologous flanking region thereof, or a combination thereof is at least 50 bp.

13. The method of claim 1 , which further comprises inserting into one or more additional endogenous loci each by targeted integration by introducing into the filamentous fungal strain a corresponding tandem construct for each locus comprising (i) a homologous 5′ region of the locus, a homologous flanking region thereof, or a combination thereof, (ii) one or more selectable markers, (iii) a polynucleotide encoding a polypeptide having biological activity operably linked to a promoter and a terminator, (iv) another polynucleotide encoding another polypeptide having biological activity operably linked to another promoter and another terminator, and (v) a homologous 3′ region of the locus, a homologous flanking region thereof, or a combination thereof.

14. The method of claim 1 , further comprising transforming the filamentous fungal host cell with a tandem construct comprising (i) one or more selectable markers, (ii) a fifth polynucleotide encoding a fifth polypeptide having biological activity operably linked to a fifth promoter and a fifth terminator, and (iii) a sixth polynucleotide encoding a sixth polypeptide having biological activity operably linked to a sixth promoter and a sixth terminator, wherein the tandem construct integrates by ectopic integration.

15. The method of claim 1 , wherein the polypeptides having biological activity are different polypeptides.

16. The method of claim 1 , wherein two or more of the polypeptides having biological activity are the same polypeptide.

17. The method of claim 1 , wherein the promoters are different promoters.

18. The method of claim 1 , wherein two or more of the promoters are the same promoter.

19. The method of claim 1 , wherein the terminators are different terminators.

20. The method of claim 1 , wherein two or more of the terminators are the same terminator.

21. The method of claim 1 , wherein the filamentous fungal strain is an Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phiebia, Pir

Assignees

• Novozymes Inc

Inventors

• Yaver Debbie
• Jin Qiming

Classifications

• C12Y302/0115

  Oligoxyloglucan reducing-end-specific cellobiohydrolase (3.2.1.150) · CPC title

• C12N9/2402

  hydrolysing O- and S- glycosyl compounds (3.2.1) · CPC title

• C12N15/87

  Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation · CPC title

• C12N15/80

  for fungi · CPC title

• C12N9/2437 Primary

  Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title